MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS), today announced the appointment of Veronica Gambillara Fonck ...

Combination vaccines can ease the logistics of vaccine management ... This has been apparent in recent outbreaks in the UK, ...

New preclinical data demonstrates that CMV antigens identified with Evaxion’s AI-Immunology™ platform trigger targeted immune responses Results ...

With the Covid-19 epidemic in Denmark under control and other vaccines available, it was decided to discontinue the use of the AZ product. Argentina has deepened Wednesday its restrictive measures ...

If we keep touting the benefits of vaccines without addressing concerns, we damage public trust,” Anton Pottegård, PhD, ...

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

(Reuters) - An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the ...

Hørsholm, Denmark, 14 November 2024 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its third quarter and year-to-date financial results for 2024. The report is available as an attachme ...

Belgium has solidified its position as a European leader in pharmaceutical research and development with a daily investment ...

Howard Lutnick has suggested Robert F. Kennedy Jr., a notorious anti-vaccine activist, may be granted access to federal ...

Pivotal Phase 3 trial (IOB-013/KN-D18) evaluating off-the-shelf therapeutic cancer vaccine IO102-IO103 in combination with Merck’s anti-PD-1 ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...